| Schedule of Dilutive Common Stock Equivalents |
The
Company had the following potentially dilutive common stock equivalents:
Schedule of Dilutive Common Stock Equivalents
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Options | |
| 1,319,394 | | |
| 1,319,394 | |
| Restricted Stock Units | |
| 1,265,443 | | |
| 852,214 | |
| Warrants | |
| 982,898 | | |
| 1,419,524 | |
| Series B Preferred Stock | |
| 3,796,907 | | |
| 3,896,907 | |
| Undeclared Cumulative Series B Preferred Stock Dividends | |
| 80,456 | | |
| 265,662 | |
| Totals | |
| 7,445,098 | | |
| 7,753,701 | |
|
| Schedule of Basic and Diluted Net Loss Per Share |
The
following table presents the calculation of the basic and diluted net loss per share and the effect of preferred stock dividends:
Schedule of Basic and Diluted Net Loss Per Share
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Numerator: | |
| | | |
| | | |
| | | |
| | |
| Net loss | |
$ | (2,085,746 | ) | |
$ | (1,690,418 | ) | |
$ | (3,847,178 | ) | |
$ | (3,969,102 | ) |
| Preferred stock dividends | |
| (191,503 | ) | |
| (207,465 | ) | |
| (380,902 | ) | |
| (421,008 | ) |
| Net loss available to common stockholders | |
| (2,277,249 | ) | |
| (1,897,883 | ) | |
| (4,228,080 | ) | |
| (4,390,110 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average shares of common stock outstanding - basic
and diluted (retroactively adjusted to January 1, 2025) | |
| 12,119,822 | | |
| 8,520,596 | | |
| 11,537,209 | | |
| 7,903,716 | |
| Basic and diluted net loss per share | |
$ | (0.19 | ) | |
$ | (0.22 | ) | |
$ | (0.37 | ) | |
$ | (0.56 | ) |
|